Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Novartis wins US nod for Humira biosimilar, but focus now on Europe
Biopharma Dive
Wed, 10/31/18 - 07:09 pm
Novartis
Hyrimoz
biosimilars
Humira
AbbVie
FDA
Genentech staff ‘funneled secrets to Taiwan biosimilar firm,’ prosecutors say
Fierce Biotech
Tue, 10/30/18 - 06:59 pm
Genentech
trade secrets
Taiwan
biosimilars
This Big Pharma Bet Isn't Paying Off Yet
Motley Fool
Sun, 10/28/18 - 07:42 pm
Big Pharma
biosimilars
Novartis
Amgen
Merck
Pfizer
Biogen
UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans
Fierce Pharma
Mon, 10/15/18 - 11:30 pm
CMS
UnitedHealthcare
Medicare
JNJ
Remicade
biosimilars
Pfizer
Merck
Here's Why Momenta Pharmaceuticals Tumbled 13.5% on Friday
Motley Fool
Fri, 10/12/18 - 11:40 pm
Momenta Pharmaceuticals
Teva Pharmaceuticals
Copaxone
Novartis
biosimilars
Glatopa
Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?
Fierce Pharma
Fri, 10/12/18 - 12:47 pm
Merck
Samsung Bioepis
Lantus
insulin
diabetes
biosimilars
Mylan Labs
Biocon
Sandoz free to launch Humira biosimilar in Europe following AbbVie deal
Pharmaforum
Fri, 10/12/18 - 10:24 am
Novartis
Sandoz
AbbVie
Humira
biosimilars
Europe
Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars
BioSpace
Thu, 10/11/18 - 09:38 am
Pfizer
Amgen
Roche
FDA
social media
biosimilars
FDA panel unanimously backs Celltrion's Rituxan biosimilar
Fierce Pharma
Wed, 10/10/18 - 10:57 pm
Celltrion
Teva Pharmaceutical
biosimilars
Rituxan
FDA
advisory panels
Trump to sign law allowing FTC to scrutinize biosimilar deals
Biopharma Dive
Wed, 10/10/18 - 12:36 pm
Donald Trump
biosimilars
antitrust
FTC
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
Fierce Pharma
Tue, 10/9/18 - 12:01 pm
Celltrion
Roche
biosimilars
Rituxan
FDA
advisory panels
Moody's picks 5 early winners in biosimilar market
Biopharma Dive
Fri, 10/5/18 - 09:01 pm
biosimilars
Pfizer
Biogen
Novartis
Amgen
Mylan Labs
Momenta starts countdown to biosimilars exit
EP Vantage
Mon, 10/1/18 - 02:55 pm
Momenta Pharmaceuticals
Mylan
biosimilars
Mylan and Novartis to FDA: Where are the Suffixes?
RAPS.org
Wed, 09/26/18 - 07:23 pm
Mylan Labs
Novartis
drug names
biosimilars
biologics
5th Humira biosimilar approved in EU as market entry nears
Biopharma Dive
Fri, 09/21/18 - 12:06 am
Europe
biosimilars
AbbVie
Humira
Mylan
Hulio
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
Forbes
Thu, 09/20/18 - 11:50 am
AbbVie
Mylan Labs
Fujifilm
biosimilars
Humira
Senate passes 'pay-for-delay' bill for biosimilars
BioCentury
Mon, 09/17/18 - 11:23 pm
biosimilars
pay-for-delay
Mylan biosimilar to stress test Amgen Neulasta franchise, analyst predicts
Biopharma Dive
Mon, 09/17/18 - 03:14 pm
Amgen
Neulasta
biosimilars
Preparing for the incoming wave of biosimilars in oncology
ESMO Open
Sun, 09/16/18 - 02:31 pm
biosimilars
oncology
cancer
Amgen, Sandoz begin biosimilar trial with top-selling Enbrel at stake
Biopharma Dive
Thu, 09/13/18 - 11:19 pm
Amgen
Sandoz
Enbrel
biosimilars
Novartis
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »